Author

M. De Weijert

Observed names: M DE WEIJERT, M de Weijert, M. de Weijert, Miryam de Weijert

Institutions: Radboud University Nijmegen, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences

Observed institutions: Radboud University Nijmegen, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences

OpenAlex ID: A5111806673

Role of E Boxes in the Repression of E-Cadherin Expression

1997 · Laurence A. Giroldi, Pierre-Paul Bringuier, et al. · Biochemical and Biophysical Research Communications · 136

Pretargeting of renal cell carcinoma: improved tumor targeting with a bivalent chelate.

1999 · O C Boerman, M H Kranenborg, et al. · PubMed · 65

Anti-endothelial cell antibodies in sera of patients with autoimmune diseases: comparison between ELISA and FACS analysis

1994 · J R WESTPHAL, A M T H BOERBOOMS, et al. · Clinical & Experimental Immunology · 57

Bone tumor–targeted delivery of theranostic 195mPt-bisphosphonate complexes promotes killing of metastatic tumor cells

2020 · R.A. Nadar, G.M. Franssen, et al. · Materials Today Bio · 25

421 Targeted dual-modality imaging in renal cell carcinoma: An ex vivo kidney perfusion study

2015 · M. Hekman, O. Boerman, et al. · European Urology Supplements · 4

The epithelial-mesenchymal transition reversing microRNA, miR-520f, sensitizes tumor cells for platinum-based chemotherapeutic drugs

2018 · J.G.M. Van Kampen, O. Van Hooij, et al. · European Urology Supplements

774 FABP7 as a potential marker and target in clear cell renal cell carcinoma

2015 · K. Nagao, N. Shinohara, et al. · European Urology Supplements

1 Dual-modality imaging bij niercelcarcinoom. Een ex-vivonierperfusiestudie

2014 · M. Hekman, O. Boerman, et al. · Tijdschrift voor Urologie

Works count: 8

Citation count: 287

H-index: 4

I10-index: 4